» Articles » PMID: 28981324

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine

Overview
Date 2017 Oct 6
PMID 28981324
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Worldwide, ∼1 million people manage their type 1 diabetes with an insulin pump and a continuous subcutaneous insulin infusion (CSII) catheter. Patients routinely insert a new catheter every 2-3 days due to increasing variability of insulin absorption over time. Catheter insertion and maintenance damage capillaries, lymphatics, cells, and connective tissue leading to an acute inflammatory response.

Methods: We compared an investigational CSII catheter (IC) and a commercial CSII catheter (CC) regarding insulin absorption pharmacokinetics (PK) and tissue inflammation. The two different catheter designs were implanted into the subcutaneous tissue of six swine for 5 days. Insulin boluses were given on days 1, 3, and 5 of wear-time to assess PK. Tissue around catheters was excised and stained to visualize inflammation and morphological changes of adjacent tissue.

Results: Insulin absorption was better when infused through a CC with highest C and fastest t values on day 5 of catheter wear-time. Both catheter types produced high intra- and intersubject day-to-day insulin absorption variability. The IC caused significantly more tissue disruption and lead to irregular changes in tissue morphology. Both catheter types were surrounded by a layer of inflammatory tissue that varied in composition, thickness, and density over time. A catheter that was manually inserted by pushing a sharp tip through the skin caused more trauma and variability than a 90° Teflon cannula with automated insertion.

Conclusions: Insulin absorption variability could be attributed to the layer of inflammatory tissue, which may function as a mechanical barrier to insulin flow into adjacent vascular tissue. The impact of the acute inflammatory tissue response on insulin absorption has to be considered in future catheter designs. A catheter that was manually inserted by pushing a sharp tip through the skin caused more trauma and variability than a 90° Teflon cannula with automated insertion.

Citing Articles

Beyond Expected Patterns in Insulin Needs of People With Type 1 Diabetes: Temporal Analysis of Automated Insulin Delivery Data.

Degen I, Robson Brown K, Reeve H, Abdallah Z JMIRx Med. 2024; 5:e44384.

PMID: 39654139 PMC: 11612581. DOI: 10.2196/44384.


Therapeutic Insulin Analogue Concentrations at Infusion Sites Enhanced the Pro-Inflammatory Response and Apoptosis in an In Vitro Macrophage-Material Interaction Model.

Zhang Y, Kuo L, Woodhouse K, Fitzpatrick L ACS Pharmacol Transl Sci. 2024; 7(8):2544-2556.

PMID: 39156741 PMC: 11325997. DOI: 10.1021/acsptsci.4c00363.


New ex vivo method to objectively assess insulin spatial subcutaneous dispersion through time during pump basal-rate based administration.

Jacquemier P, Retory Y, Virbel-Fleischman C, Schmidt A, Ostertag A, Cohen-Solal M Sci Rep. 2023; 13(1):20052.

PMID: 37973963 PMC: 10654403. DOI: 10.1038/s41598-023-46993-1.


Closed loop insulin delivery-Opportunities and limitations.

Weiss R J Diabetes. 2023; 15(12):1103-1106.

PMID: 37855262 PMC: 10755602. DOI: 10.1111/1753-0407.13490.


MyD88-dependent Toll-like receptor 2 signaling modulates macrophage activation on lysate-adsorbed Teflon™ AF surfaces in an biomaterial host response model.

McKiel L, Ballantyne L, Negri G, Woodhouse K, Fitzpatrick L Front Immunol. 2023; 14:1232586.

PMID: 37691934 PMC: 10491479. DOI: 10.3389/fimmu.2023.1232586.


References
1.
Swan K, Dziura J, Steil G, Voskanyan G, Sikes K, Steffen A . Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2008; 32(2):240-4. PMC: 2628686. DOI: 10.2337/dc08-0595. View

2.
Clausen T, Kaastrup P, Stallknecht B . Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther. 2009; 11(9):575-80. DOI: 10.1089/dia.2009.0058. View

3.
Golden S, Sapir T . Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. J Manag Care Pharm. 2012; 18(6 Suppl):S1-17. PMC: 10438109. DOI: 10.18553/jmcp.2012.18.s6-a.1. View

4.
Plum A, Agerso H, Andersen L . Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs. Drug Metab Dispos. 2000; 28(2):155-60. View

5.
Thomsen M, Hernandez-Garcia A, Mathiesen J, Poulsen M, Sorensen D, Tarnow L . Model study of the pressure build-up during subcutaneous injection. PLoS One. 2014; 9(8):e104054. PMC: 4133188. DOI: 10.1371/journal.pone.0104054. View